Sun Financial Statements From 2010 to 2024

Stocks . India . 
Stock . Sun Pharmaceutical Industries
SUNPHARMA   1,734  15.20  0.87%   
Sun Pharmaceutical financial statements provide useful quarterly and yearly information to potential Sun Pharmaceutical Industries investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Sun Pharmaceutical financial statements helps investors assess Sun Pharmaceutical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Sun Pharmaceutical's valuation are summarized below:
Gross Profit
332.2 B
Profit Margin
0.2197
Market Capitalization
4.2 T
Enterprise Value Revenue
8.0703
Revenue
503.1 B
There are over ninety available fundamental trend indicators for Sun Pharmaceutical Industries, which can be analyzed over time and compared to other ratios. Investors and active traders are advised to double-check Sun Pharmaceutical's current fundamental performance against the performance between 2010 and 2024 to make sure the trends are evolving in the right direction.

Sun Pharmaceutical Total Revenue

501.46 Billion

Check Sun Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sun Pharmaceutical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 26.8 B, Interest Expense of 1.5 B or Total Revenue of 501.5 B, as well as many indicators such as . Sun financial statements analysis is a perfect complement when working with Sun Pharmaceutical Valuation or Volatility modules.
  
This module can also supplement various Sun Pharmaceutical Technical models . Check out the analysis of Sun Pharmaceutical Correlation against competitors.

Sun Pharmaceutical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets897.4 B854.6 B548.9 B
Slightly volatile
Short and Long Term Debt Total42.5 B32.7 B53.2 B
Pretty Stable
Other Current Liabilities82.1 B78.2 B51.5 B
Slightly volatile
Total Current Liabilities97.9 B169.8 B128.2 B
Slightly volatile
Total Stockholder Equity668.5 B636.7 B364 B
Slightly volatile
Property Plant And Equipment Net65.9 B113 B82.1 B
Slightly volatile
Current Deferred Revenue1.2 B1.3 B39.9 B
Slightly volatile
Retained Earnings526.6 B501.5 B280.5 B
Slightly volatile
Accounts Payable59.4 B56.5 B35.3 B
Slightly volatile
Cash97.5 B92.9 B58.3 B
Slightly volatile
Non Current Assets Total441.3 B420.3 B266.9 B
Slightly volatile
Non Currrent Assets Other45.2 B69.8 B54.5 B
Very volatile
Cash And Short Term Investments203 B193.3 B118 B
Slightly volatile
Net Receivables56.9 B112.6 B71.2 B
Slightly volatile
Common Stock Shares Outstanding2.4 B2.8 B2.3 B
Slightly volatile
Liabilities And Stockholders Equity897.4 B854.6 B548.9 B
Slightly volatile
Non Current Liabilities Total20.5 B13.7 B23.2 B
Very volatile
Inventory108.1 B102.9 B66.1 B
Slightly volatile
Other Current Assets28.6 B28.3 B36.9 B
Pretty Stable
Other Stockholder Equity12.6 B11.9 B12.9 B
Very volatile
Total Liabilities118.4 B183.6 B151.3 B
Slightly volatile
Total Current Assets456 B434.3 B282 B
Slightly volatile
Short Term Debt34.4 B29.7 B41.7 B
Slightly volatile
Intangible Assets91 B86.7 B45.4 B
Slightly volatile
Common Stock1.9 B2.8 B2 B
Slightly volatile
Good Will51.8 B86 B50 B
Slightly volatile
Short Term Investments66.9 B100.4 B59.3 B
Slightly volatile
Other Liabilities13.3 B9.5 B17.9 B
Slightly volatile
Net Tangible Assets297.8 B407.5 B263.5 B
Slightly volatile
Other Assets233.8 M246.1 M39.7 B
Very volatile
Long Term Debt12.6 M13.3 M8.4 B
Very volatile
Deferred Long Term Liabilities880 K990 K1.1 M
Slightly volatile
Long Term Investments47.7 B45.4 B26.2 B
Slightly volatile
Short and Long Term Debt48.5 B28.4 B40.7 B
Pretty Stable
Property Plant Equipment108 B130.6 B90 B
Slightly volatile
Long Term Debt Total4.8 B5 B18.9 B
Slightly volatile
Capital Surpluse10.2 B10.7 B14.4 B
Slightly volatile
Capital Lease Obligations2.7 B4.3 B1.8 B
Slightly volatile
Non Current Liabilities Other3.5 B5 B2 B
Slightly volatile
Cash And Equivalents11.9 B12.5 B37.3 B
Slightly volatile
Net Invested Capital597.9 B665.1 B519.2 B
Slightly volatile
Net Working Capital188.6 B264.9 B147.5 B
Slightly volatile
Capital Stock1.9 B2.2 B2.4 B
Slightly volatile
Property Plant And Equipment Gross133.1 B113 B179.2 B
Slightly volatile

Sun Pharmaceutical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization26.8 B25.6 B14.6 B
Slightly volatile
Total Revenue501.5 B477.6 B280.7 B
Slightly volatile
Gross Profit141 B229.5 B177.7 B
Slightly volatile
Other Operating Expenses398.1 B379.2 B217 B
Slightly volatile
Operating Income109.5 B104.3 B64.4 B
Slightly volatile
EBIT118.4 B112.8 B61.5 B
Slightly volatile
EBITDA145.3 B138.4 B76.1 B
Slightly volatile
Cost Of Revenue260.5 B248.1 B96.3 B
Slightly volatile
Total Operating Expenses374.7 B356.9 B151.5 B
Slightly volatile
Income Before Tax116.4 B110.9 B57.7 B
Slightly volatile
Net Income100.6 B95.8 B45.4 B
Slightly volatile
Income Tax Expense15.1 B14.4 B8.5 B
Slightly volatile
Research Development32.8 B31.3 B18.3 B
Slightly volatile
Selling General Administrative19.8 B34.4 B17.2 B
Slightly volatile
Selling And Marketing Expenses29.1 B57.8 B25.3 B
Slightly volatile
Net Income From Continuing Ops56.6 B96.1 B49.3 B
Slightly volatile
Net Income Applicable To Common Shares102.3 B97.4 B47.8 B
Slightly volatile
Tax Provision9.9 B14.4 B9.1 B
Pretty Stable
Interest Income10.7 B10.2 B3.6 B
Slightly volatile
Reconciled Depreciation23 B25.6 B18.3 B
Slightly volatile

Sun Pharmaceutical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow39.6 B46.2 B48.7 B
Slightly volatile
Depreciation26.8 B25.6 B14.6 B
Slightly volatile
Dividends Paid30.4 B29 B11.6 B
Slightly volatile
Capital Expenditures14.7 B22 B18.2 B
Pretty Stable
Total Cash From Operating Activities127.4 B121.3 B57.9 B
Slightly volatile
Net Income100.6 B95.8 B55.6 B
Slightly volatile
End Period Cash Flow97.5 B92.9 B58.3 B
Slightly volatile

Sun Fundamental Market Drivers

Forward Price Earnings26.9542
Cash And Short Term Investments193.3 B

About Sun Pharmaceutical Financial Statements

Sun Pharmaceutical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Sun Pharmaceutical investors may analyze each financial statement separately, they are all interrelated. The changes in Sun Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Sun Pharmaceutical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue1.3 B1.2 B
Total Revenue477.6 B501.5 B
Cost Of Revenue248.1 B260.5 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C

Additional Tools for Sun Stock Analysis

When running Sun Pharmaceutical's price analysis, check to measure Sun Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sun Pharmaceutical is operating at the current time. Most of Sun Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Sun Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sun Pharmaceutical's price. Additionally, you may evaluate how the addition of Sun Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY